Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
What Does Secretary Becerra Mean for Drug Prices?
In March, the U.S. Senate voted to confirm Xavier Becerra as secretary of the Department of Health and Human Services despite…
House of Representatives Reintroduces Focus on Drug Prices
On April 22, 2021, leadership from the United States House of Representatives reintroduced H.R. 3, the Elijah E. Cummings Lower…
Editorial Outlines Four Potential Paths the Biden Administration Should…
Recently, Robert Popovian, Pharm.D., MS., and Wayne Winegarden, Ph.D., wrote an opinion piece for Morning Consult, advocating for…
States Moving Forward with Canadian Drug Importation Plans, Despite No…
Several states are plowing forward with their efforts to import prescription drugs from Canada to their state, despite no clear…
Twenty-Eight States Demand Laws Be Enforced on 340B Drug Pricing
On December 14, 2020, the attorneys general for twenty-eight states sent a letter to United States Health and Human Service…
MFN Rule Facing an Uphill Battle
Two recent updates are problematic for the Trump administration’s Most Favored Nations rule (MFN). An analysis by Avalere shows…
Canadian Industry Group Attempts to Stymie New Drug Pricing Rules
In mid-December 2020, Reuters reported that the pharmaceutical industry in Canada is trying a last-ditch effort to stop certain…
PhRMA Files Motion for Restraining Order and Preliminary Injunction in MFN…
On December 10, 2020, the Pharmaceutical Research and Manufacturers of America (PhRMA), the Association of Community Cancer…
PhRMA Files Suit to Stop Drug Importation from Canada
On Monday, November 23, 2020, the Pharmaceutical Research and Manufacturers of America (PhRMA), along with the Partnership for…
Patient and Provider Groups Call on Congress to Stop CMS Policy
Recently, the All Copays Count Coalition (ACCC) sent a letter to House of Representatives Speaker Nancy Pelosi and Minority Leader…